Peter Lynch fit · Growth at a reasonable price (GARP)
Is Caris Life Sciences, Inc. Common Stock (CAI) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
63/100
CSeñales mixtas
3/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a CAI
PEG ≤ 1.0
clave—
EPS CAGR ≥ 15%
clave26.0%
Revenue CAGR ≥ 10%
93.9%
Net margin > 0
-28.9%
Cómo se valora CAI en otras estrategias
Datos financieros en vivo
Cap. mercado
$7.05B
PER (TTM)
-
ROIC (TTM)
-
Margen bruto
61.3%
Preguntas frecuentes
What is CAI's Peter Lynch fit score?
CAI scores 63/100 on our Peter Lynch fit engine — grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own CAI?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CAI.
How often is this score updated?
CAI's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende CAI personalmente.